EX-99.1 2 atomera_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

 

 

Atomera Provides Third Quarter 2024 Results

 

LOS GATOS, Calif. Oct. 29, 2024 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2024.

 

Recent Company Highlights

 

·Announced a collaboration with the Center for Integrated Nanotechnologies (CINT) at Sandia National Laboratories to validate MST’s ability to address GaN manufacturing challenges
·Presented on the advantages of using MST in multiple applications at PRiME 2024

 

Management Commentary

 

“Our recent collaboration with Sandia National Laboratories CINT highlights the expanding opportunities for Atomera in the power segment of the semiconductor industry to supplement the strong progress we’ve made with our lead customer in this area,” said Scott Bibaud, President and CEO. “We are optimistic about accelerating engagements in our other segments which we believe will lead to the announcement of licenses and JDAs with more customers in the near term.”

 

Financial Results

 

The Company incurred a net loss of ($4.6) million, or ($0.17) per basic and diluted share in the third quarter of 2024, compared to a net loss of ($5.0) million, or ($0.20) per basic and diluted share, for the third quarter of 2023. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2024 was a loss of ($3.9) million compared to an adjusted EBITDA loss of ($4.3) million in the third quarter of 2023.

 

The Company had $17.3 million in cash, cash equivalents and short-term investments as of Sept. 30, 2024, compared to $19.5 million as of December 31, 2023.

 

The total number of shares outstanding was 28.3 million as of September 30, 2024.

 

Second Quarter 2024 Results Webinar

 

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, Oct. 29, 2024

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

 

 

 

 1 

 

 

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

 

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com.  

 

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and knowhow and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2024. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

 

-- Financial Tables Follow –

 

 

 

 

 

 

 

 2 

 

 

Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

 

   September 30,   June 30,   December 31, 
   2024   2024   2023 
   (Unaudited)   (Unaudited)     
ASSETS               
                
Current assets:               
Cash and cash equivalents  $13,757    14,484   $12,591 
Short-term investments   3,585    3,804    6,940 
Accounts receivable   6    6     
Unbilled contracts receivable           550 
Interest receivable   56    74    79 
Prepaid expenses and other current assets   388    578    244 
Total current assets   17,792    18,946    20,404 
                
Property and equipment, net   63    75    100 
Long-term prepaid maintenance and supplies   91    91    91 
Security deposit   14    14    14 
Operating lease right-of-use asset   341    401    517 
Financing lease right-of-use-asset   1,839    2,341    2,903 
Total assets  $20,140   $21,868   $24,029 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY               
                
Current liabilities:               
Accounts payable  $786   $646   $618 
Accrued expenses   172    249    222 
Accrued payroll related expenses   968    594    1,382 
Current operating lease liability   258    256    264 
Current financing lease liability   1,194    1,386    1,328 
Deferred revenue   8    13     
Total current liabilities   3,386    3,144    3,814 
                
Long-term operating lease liability   80    137    295 
Long-term financing lease liability   781    1,108    1,750 
Total liabilities   4,247    4,389    5,859 
                
Commitments and contingencies               
                
Stockholders’ equity:               
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of September 30,2024,  June 30, 2024 and December 31, 2023            
Common stock: $0.001 par value, authorized 47,500 shares; 28,289 shares issued and outstanding as of September 30, 2024: 27,622 shares issued and 27,610 outstanding as of June 30, 2024; and 26,107 shares issued and outstanding as of December 31, 2023   28    28    26 
Additional paid-in capital   232,726    229,726    221,229 
Other comprehensive income(loss)   2    (7)    
Accumulated deficit   (216,863)   (212,268)   (203,085)
Total stockholders’ equity   15,893    17,479    18,170 
Total liabilities and stockholders’ equity  $20,140   $21,868   $24,029 

 

 

 

 3 

 

 

Atomera Incorporated

Condensed Statements of Operations

(Unaudited)

(in thousands, except per share data)

 

 

   Three Months Ended   Nine Months Ended 
   September 30,   June 30,   September 30,   September 30, 
   2024   2024   2023   2024   2023 
Revenue  $22   $72   $   $112   $ 
Cost of revenue   (3)   (74)       (110)    
Gross margin   19    (2)       2     
                          
Operating expenses                         
Research and development   2,759    2,589    3,305    8,206    9,533 
General and administrative   1,812    1,832    1,683    5,455    5,200 
Selling and marketing   248    207    365    805    1,147 
Total operating expenses   4,819    4,628    5,353    14,466    15,880 
                          
Loss from operations   (4,800)   (4,630)   (5,353)   (14,464)   (15,880)
                          
Other income (expense)                         
Interest income   176    185    177    566    528 
Accretion income   59    47    112    152    221 
Interest expense   (30)   (35)   (47)   (104)   (151)
Other income, net       72    72    72    72 
Total other income (expense), net   205    269    314    686    670 
                          
Net loss  $(4,595)  $(4,361)  $(5,039)  $(13,778)  $(15,210)
                          
Net loss per common share, basic and diluted  $(0.17)  $(0.16)  $(0.20)  $(0.52)  $(0.62)
                          
Weighted average number of common shares outstanding, basic and diluted   27,406    26,467    25,255    26,640    24,536 

 

 

 

 4 

 

 

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

 

 

   Three Months Ended   Nine Months Ended 
   September 30,   June 30,   September 30,   September 30, 
   2024   2024   2023   2024   2023 
Net loss (GAAP)  $(4,595)  $(4,361)  $(5,039)  $(13,778)  $(15,210)
Depreciation and amortization   12    13    20    42    60 
Stock-based compensation   907    987    1,041    2,918    2,998 
Interest income   (176)   (185)   (177)   (566)   (528)
Accretion income   (59)   (47)   (112)   (152)   (221)
Interest expense   30    35    47    104    151 
Other income, net       (72)   (72)   (72)   (72)
Net loss non-GAAP EBITDA  $(3,881)  $(3,630)  $(4,292)  $(11,504)  $(12,822)

 

 

 

Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633

investor@atomera.com

 

 

 

 

 

 5